paclitaxel was first identified in 1971 as a potent anticancer compound. Originally isolated from the bark of the Pacific yew tree (Taxus brevifolia Nutt.), it has since been produced through synthetic and semi-synthetic approaches, ensuring broader accessibility for clinical and research use.